Literature DB >> 16043218

Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature.

Kalyani Narra1, Hossein Borghaei, Tahseen Al-Saleem, Martin Höglund, Mitchell R Smith.   

Abstract

Pure red cell aplasia (PRCA) is an unusual cause of anemia in patients with chronic lymphoproliferative disorders. Here, we present two cases of PRCA, one associated with chronic lymphocytic leukemia (CLL) and the other with splenic marginal zone lymphoma, in which the PRCA responded dramatically to treatment with rituximab. We then review the literature on PRCA in lymphoma and response to rituximab. PRCA associated with CLL or lymphoma may be another indication for rituximab therapy.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16043218     DOI： 10.1016/j.leukres.2005.05.017

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  18 in total

1.  A diagnostic dilemma in stem cell transplantation for beta-thalassemia major: progressive loss of take or pure red cell aplasia?

Authors:  Giuseppe Visani; Moira Lucesole; Giuliana Leopardi; Barbara Guiducci; Claudio Giardini; Alessandro Isidori
Journal:  Int J Hematol       Date:  2007-12       Impact factor: 2.490

2.  Waldenström's macroglobulinaemia complicated by pure red cell aplasia: a case report.

Authors:  Yuan-Yuan Li; Lei Fan; Li Wang; Ji Xu; Jian-Yong Li; Wei Xu
Journal:  Blood Transfus       Date:  2013-05-27       Impact factor: 3.443

Review 3.  A Concise Review of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia.

Authors:  Mazie Tsang; Sameer A Parikh
Journal:  Curr Hematol Malig Rep       Date:  2017-02       Impact factor: 3.952

4.  Pure red cell aplasia complicating B cell small lymphocytic lymphoma: a case report.

Authors:  Efthimia Vlachaki; Konstantinos Tselios; Stella Charalambidou; Elizabeth Ioannidou; Ioannis Klonizakis
Journal:  Int J Hematol       Date:  2008-09-03       Impact factor: 2.490

5.  Anaemia in CD5 Negative Chronic Lymphoproliferative Disorder: Importance of Bone Marrow Examination.

Authors:  Mili Jain; Ayush Shukla; Ashutosh Kumar; Rashmi Kushwaha; Anil Kumar Tripathi
Journal:  J Clin Diagn Res       Date:  2017-04-01

Review 6.  Autoimmune complications in chronic lymphocytic leukaemia (CLL).

Authors:  Clive S Zent; Neil E Kay
Journal:  Best Pract Res Clin Haematol       Date:  2010-03       Impact factor: 3.020

7.  Thymoma with Concomitant Pure Red Cell Aplasia, Good's Syndrome and Myasthenia Gravis Responding to Rituximab.

Authors:  Ahmad I Antar; Zaher K Otrock; Mohamed A Kharfan-Dabaja; Rami A Mahfouz; Raafat S Alameddine; Nadim M W El-Majzoub; Ziad M Salem
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-11       Impact factor: 0.900

Review 8.  Update on chronic lymphocytic leukemia: overview of new agents and comparative analysis.

Authors:  Sanford Kempin
Journal:  Curr Treat Options Oncol       Date:  2013-06

9.  Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report.

Authors:  Caroline M Behler; Norah A Terrault; Joan E Etzell; Lloyd E Damon
Journal:  J Med Case Rep       Date:  2009-07-06

10.  Pure red cell aplasia as first manifestation of splenic marginal zone lymphoma-successful treatment with rituximab: a case report.

Authors:  Athanasios Anastasiadis; Dimitrios Margaritis; Ioannis Kotsianidis; Emmanouil Spanoudakis; Anna Christoforidou; Ioannis Kostopoulos; Constantinos Tsatalas
Journal:  Cases J       Date:  2009-08-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.